We present a case of 9p– syndrome with a complex chromosomal event originally characterized by the classical karyotype approach as 46,XX,der(9)t(9;13)(p23;q13). We used advanced technologies (Bionano Genomics genome imaging and 10× Genomics sequencing) to characterize the location of the translocation and accompanying deletion on Chromosome 9 and duplication on Chromosome 13 with single-nucleotide breakpoint resolution. The translocation breakpoint was at Chr 9:190938 and Chr 13:50850492, the deletion at Chr 9:1–190938, and the duplication at Chr 13:50850492–114364328. We identified genes in the deletion and duplication regions that are known to be associated with this patient’s phenotype (e.g., ZIC2 in dysmorphic facial features, FOXD4 in developmental delay, RNASEH2B in developmental delay, and PCDH9 in autism). Our results indicate that clinical genomic assessment of individuals with complex karyotypes can be refined to a single-base-pair resolution when utilizing Bionano and 10× Genomics sequencing. With the 10× Genomics data, we were also able to characterize other variation (e.g., loss of function) throughout the remainder of the patient’s genome. Overall, the Bionano and 10× technologies complemented each other and provided important insight into our patient with 9p–syndrome. Altogether, these results indicate that newer technologies can identify precise genomic variants associated with unique patient phenotypes that permit discovery of novel genotype–phenotype correlations and therapeutic strategies.

Original languageEnglish
Article numbera005348
JournalCold Spring Harbor molecular case studies
Issue number3
StatePublished - Feb 2020


Dive into the research topics of 'Precise breakpoint detection in a patient with 9p– syndrome'. Together they form a unique fingerprint.

Cite this